<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01521156</url>
  </required_header>
  <id_info>
    <org_study_id>NU312</org_study_id>
    <nct_id>NCT01521156</nct_id>
  </id_info>
  <brief_title>Effect of the Consumption of a Fermented Dairy Product Enriched With Plant Sterols</brief_title>
  <official_title>Cholesterol Lowering Effects of a Drinkable Low Fat Dairy Product Enriched With Plant Sterols</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danone Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danone Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the cholesterol lowering effect of a drinkable&#xD;
      low fat fermented milk enriched with plant sterols after 3 weeks of daily consumption in&#xD;
      midly hypercholesterolemic people.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Mild Hypercholesterolemic Subjects</condition>
  <arm_group>
    <arm_group_label>1 = Control product</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2 = Tested product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>1- low-fat dairy fermented product (drinkable) enriched with plant sterols-esters (1,6g /day equivalent as free sterols).</intervention_name>
    <description>1 = Intervention 1 (1 test product/day)</description>
    <arm_group_label>1 = Control product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2- low-fat dairy fermented product (drinkable) enriched with experimental plant sterols-esters (1,6g /day equivalent as free sterols).</intervention_name>
    <description>2 = Intervention 2 (1 test product/day)</description>
    <arm_group_label>2 = Tested product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male/female subject, aged from 18 to 75,with BMI between 18,5 and 30 kg/mÂ², with&#xD;
             LDL-cholesterol blood level between 130 mg/dL to 190 mg/dL without statin therapy.&#xD;
&#xD;
          -  Subject accepting to follow the dietary recommendations advisable for&#xD;
             hypercholesterolemic subject.&#xD;
&#xD;
          -  Subject used to consume dairy products.&#xD;
&#xD;
          -  For female subjects: effective contraceptive methods used.&#xD;
&#xD;
          -  Subject having given written consent to take part in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject with blood triglycerides levels above 350 mg/dL.&#xD;
&#xD;
          -  Subject having experienced any cardiovascular event in the last 6 months.&#xD;
&#xD;
          -  Subject having sitosterolemia.&#xD;
&#xD;
          -  Subject taking any hypocholesterolemic treatment drugs.&#xD;
&#xD;
          -  Intake of blood lipid-regulating supplementation of blood lipid-regulating dietary&#xD;
             supplements or functional food during the last 2 weeks before study start.&#xD;
&#xD;
          -  Diabetic subject (type I and type II).&#xD;
&#xD;
          -  Subject smoking strictly more than 10 cigarettes / day.&#xD;
&#xD;
          -  Subject with heavy alcohol intake (&gt; 40 g / day for men ; &gt; 30 g / day for women).&#xD;
&#xD;
          -  Subject presenting known allergy or hypersensitivity to milk proteins.Subject with&#xD;
             known soy allergy.&#xD;
&#xD;
          -  Subject refusing to stop the consumption of plant sterols-enriched products if any&#xD;
             during the study (other than the studied product).&#xD;
&#xD;
          -  Subject receiving systemic treatment or topical treatment likely to interfere with&#xD;
             evaluation of the study parameters.&#xD;
&#xD;
          -  Subject receiving a transplant and under immunosuppressor treatment.&#xD;
&#xD;
          -  Subject currently involved in a clinical trial or in an exclusion period following&#xD;
             participation in another clinical trial.&#xD;
&#xD;
          -  Subject in a situation which in the investigator's opinion could interfere with&#xD;
             optimal participation in the present study or could constitute a special risk for the&#xD;
             subject.&#xD;
&#xD;
          -  Subject with any kind of disease likely to interfere with the evaluation of efficiency&#xD;
             or safety of the product.&#xD;
&#xD;
          -  For female subject: pregnancy, breast feeding or intention to be pregnant during the&#xD;
             study.&#xD;
&#xD;
          -  For female subject: subject likely to change her contraceptive method during the&#xD;
             study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Harrison Clinical Research Clinical Unit</name>
      <address>
        <city>Munich</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>January 26, 2012</study_first_submitted>
  <study_first_submitted_qc>January 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2012</study_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Plant sterols - Hypercholesterolemia - Diet - Dairy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

